Gaia (London) key facts
as of Oct 2026- Provider of medical insurance services intended to cover in vitro fertilization outcome risks.
- Gaia (London) is valued at approximately $125.2M as of Oct 2026 (last reported valuation).
- It has raised $38.2M; the latest was Later Stage VC ($15.0M) in Jul 2025.
- Notable investors include FJ Labs, Seedcamp, Clocktower Ventures, Atomico, Lloyd's Lab — 14 tracked in total.
- Status: Privately Held (backing).
Gaia (London)'s last reported valuation, Feb 2022. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Gaia (London): the Monday email on marks, rounds and moves
Gaia (London) funding rounds
No funding rounds for Gaia (London) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Gaia (London)
14+Gaia (London) valuation
Gaia (London)'s last reported valuation was $125 million in Feb 2022. No priced round, secondary trade or fund mark has surfaced since.
Gaia (London) investors
14 investors are on record for Gaia (London), including FJ Labs, Seedcamp, Clocktower Ventures and Atomico. By type, the record holds 6 venture capital firms and 1 asset manager.
About Gaia (London)
Provider of medical insurance services intended to cover in vitro fertilization outcome risks. The company's service offers personalized success prediction and tailored insurance plans that combine reproductive health data with financial aspects, enabling individuals to access treatments that are more accessible and affordable and protect them from spiraling costs.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 23
- Website
- gaiafamily.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.